Elite Pharmaceuticals (ELTP) Payables (2009 - 2026)
Elite Pharmaceuticals' Payables came in at $3.1 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 9.6% from $3.42 million a year earlier and down 44.6% from the prior quarter.
Elite Pharmaceuticals (ELTP) Payables (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Payables was $6.05 million, down 13.0% from FY2025.
- Payables carries a five-year compound annual growth rate of 45.5% (FY2021 to FY2026).
- Going back by fiscal year, Payables was $6.96 million in FY2025 (+3.6%), $6.71 million in FY2024 (+174.4%), $2.45 million in FY2023 (+71.0%) and $1.43 million in FY2022 (+53.9%).
- The fiscal Q2 2027 figure represents the lowest quarterly Payables since fiscal Q4 2023.
- Year-over-year, Payables increased in three of the last eight quarters, with an average decline of 8.2%.
- The fastest year-over-year change in Payables over five years came in fiscal Q3 2024 (growth of 368.1%), and the weakest in fiscal Q2 2026 (a decline of 42.8%).
- Business Quant data shows ELTP's Payables at $5.59 million (Q1 2027), $6.05 million (Q4 2026) and $6.52 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,291.18 Bn | 1,264.79 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 686.56 Bn | 606.42 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 525.29 Bn | 493.30 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 362.24 Bn | 325.18 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 313.66 Bn | 286.90 Bn | - | - |
| 6 | Astrazeneca | 286.68 Bn | 260.20 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 253.44 Bn | 205.10 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 210.62 Bn | 185.73 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 165.41 Bn | 112.77 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Elite Pharmaceuticals | 397.46 Mn | 270.87 Mn | 15.99 Mn | 3.10 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.10 Mn |
| Jun 30, 2026 | 5.59 Mn |
| Mar 31, 2026 | 6.05 Mn |
| Dec 31, 2025 | 6.52 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Jun 30, 2025 | 5.09 Mn |
| Mar 31, 2025 | 6.96 Mn |
| Dec 31, 2024 | 9.84 Mn |
| Sep 30, 2024 | 5.98 Mn |
| Jun 30, 2024 | 6.61 Mn |
| Mar 31, 2024 | 6.71 Mn |
| Dec 31, 2023 | 6.89 Mn |
| Sep 30, 2023 | 7.61 Mn |
| Jun 30, 2023 | 5.87 Mn |
| Mar 31, 2023 | 2.45 Mn |
| Dec 31, 2022 | 1.47 Mn |
| Sep 30, 2022 | 1.72 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | 1.28 Mn |
Elite Pharmaceuticals Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ELTP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();